Skip to content
DMRADamora Therapeutics, Inc.

DMRA holders

Who holds Damora Therapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Managers
114
Shares held
63.1M
Value held
$1.3B
Opened
29
Closed
16

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Osaic Holdings, Inc.39+3,800.0%$8300%Nov 12, 2026
US Bancorp34New$7240%Nov 5, 2026
Rothschild Investment LLC30−11.8%$6380%Nov 10, 2026
Allworth Financial LP24+242.9%$5110%Nov 17, 2026
PNC Financial Services Group, Inc.23New$4890%Nov 6, 2026
SBI Securities Co., Ltd.15+7.1%$3190%Oct 22, 2026
SJS Investment Consulting Inc.10New$2130%Oct 26, 2026
Ascentis Wealth Management, LLC9New$1910%Nov 3, 2026
Arax Advisory Partners7+40.0%$1490%Nov 12, 2026
Russell Investments Group, Ltd.6−99.9%$1280%Nov 6, 2026
Hughes Financial Services, LLC4New$880%Oct 30, 2026
Vestcor Inc2KNew$420.1%Nov 12, 2026
Keating Financial Advisory Services, Inc.1New$210%Nov 12, 2026
Covestor Ltd10New$00%Oct 30, 2026